Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
For metabolic traits, type 2 diabetes was positively associated with fornix FAFWcorr and AxDFWcorr, whereas hydroxyvitamin D demonstrated several positive associations with MDFWcorr and RDFWcorr.
Source: Genetic covariance between WM microstructure with cardiovascular, lipid, inflammatory, and neurological traits. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Review / evidence synthesis.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
We estimated single nucleotide polymorphism (SNP) heritability, performed cohort genome‐wide association studies (GWASs) with meta‐analysis, evaluated shared genetic architecture and enriched pathways, and assessed AD relevance using brain RNA‐seq data.
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Genetic architecture of the limbic white matter microstructure in aging and Alzheimer's Disease
Review / evidence synthesis · Alzheimer's & Dementia · 2026
Original publication title
Genetic architecture of the limbic white matter microstructure in aging and Alzheimer's Disease
© 2026 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Limbic white matter (WM) abnormalities are prevalent in aging and Alzheimer's disease (AD), but genetic drivers are unclear.
Source: INTRODUCTIONAbstract: What methods does the paper describe?
In 2614 older adults (mean age ± SD: 73.7 ± 9.8 years; 26% cognitively impaired) from seven harmonized cohorts enriched for cognitive impairment, we quantified free‐water: corrected diffusion MRI (dMRI) metrics in seven limbic tracts. We estimated single nucleotide polymorphism (SNP) heritability, performed cohort genome‐wide association studies (GWASs) with meta‐analysis, evaluated shared genetic architecture and enriched pathways, and assessed AD relevance using brain RNA‐seq data.
Source: METHODSAbstract: DISCUSSION
Limbic WM microstructure is genetically influenced and links oligodendrocyte and vascular‐inflammatory biology to AD‐relevant outcomes.
Source: DISCUSSIONAbstract: RESULTS
Limbic WM is heritable (h2 = 0.26 to 0.60; pFDR < 0.05). Meta‐GWAS identified six loci (p < 5 × 10− 8), including a signal implicating CDH19, an oligodendrocyte‐enriched cell‐adhesion gene. Additional loci were near the KC6, SENP5, RORA, FAM107B, and MIR548A1 genes. In brain tissue, RORA, FAM107B, and KC6 expression was associated with cognition and AD neuropathology. Results converged on insulin and immune biology and shared genetic architecture with lipid and cardiovascular traits.
Source: RESULTSAuthors’ abstract
Abstract
INTRODUCTION
Limbic white matter (WM) abnormalities are prevalent in aging and Alzheimer's disease (AD), but genetic drivers are unclear.
METHODS
In 2614 older adults (mean age ± SD: 73.7 ± 9.8 years; 26% cognitively impaired) from seven harmonized cohorts enriched for cognitive impairment, we quantified free‐water: corrected diffusion MRI (dMRI) metrics in seven limbic tracts. We estimated single nucleotide polymorphism (SNP) heritability, performed cohort genome‐wide association studies (GWASs) with meta‐analysis, evaluated shared genetic architecture and enriched pathways, and assessed AD relevance using brain RNA‐seq data.
RESULTS
Limbic WM is heritable (h2 = 0.26 to 0.60; pFDR < 0.05). Meta‐GWAS identified six loci (p < 5 × 10− 8), including a signal implicating CDH19, an oligodendrocyte‐enriched cell‐adhesion gene. Additional loci were near the KC6, SENP5, RORA, FAM107B, and MIR548A1 genes. In brain tissue, RORA, FAM107B, and KC6 expression was associated with cognition and AD neuropathology. Results converged on insulin and immune biology and shared genetic architecture with lipid and cardiovascular traits.
DISCUSSION
Limbic WM microstructure is genetically influenced and links oligodendrocyte and vascular‐inflammatory biology to AD‐relevant outcomes.
Highlights
Limbic free‐water (FW): corrected white matter (WM) integrity is heritable in late‐life aging
Six genome‐wide loci discovered for limbic WM traits in Alzheimer's disease (AD): enriched cohorts
Chr18 locus implicates CDH19, linking oligodendrocyte biology to WM microstructure
RORA, FAM107B, and KC6 expression tracks cognitive decline and AD neuropathology
Publication and source details
Original title: Genetic architecture of the limbic white matter microstructure in aging and Alzheimer's Disease
Anna S Lorenz; Aditi Sathe; Yisu Yang; Alaina Durant; Yiyang Wu; Michael E. Kim; Chenyu Gao; Nancy R. Newlin; Karthik Ramadass; Praitayini Kanakaraj; Nazirah Mohd Khairi; Zhiyuan Li; Tianyuan Yao; Yuankai Huo; Logan Dumitrescu; Niranjana Shashikumar; Kimberly R. Pechman; Shannon L. Risacher; Lori L. Beason‐Held; Yang An; Konstantinos Arfanakis; Guray Erus; Christos Davatzikos; Mohamad Habes; Di Wang; Duygu Tosun; Arthur W. Toga; Paul M. Thompson; Elizabeth C. Mormino; Panpan Zhang; Kurt Schilling; Marilyn Albert; Walter Kukull; Sarah A. Biber; Bennett A. Landman; Sterling C. Johnson; Barbara Bendlin; Julie Schneider; David A. Bennett; Angela L. Jefferson; Susan M. Resnick; Andrew J. Saykin; Jennifer E. Below; Timothy J. Hohman; Derek B. Archer; Alzheimer's Disease Neuroimaging Initiative (ADNI); The BIOCARD Study Team (BIOCARD); The Alzheimer's Disease Sequencing Project (ADSP)
Alzheimer's & Dementia · 2026
* CorrespondenceDerek B. Archer: Vanderbilt Memory and Alzheimer's Center 3319 West End Ave, Floor 8, Room 848 Nashville, TN 37203.
Email: derek.archer@vumc.org
© 2026 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. National Institutes of Health10.13039/100000002 K01‐EB03289R01‐EB017230R01‐AG074339P30‐AG066515K01‐AG073584U24‐AG07485575N95D22P00141R01‐AG059716UL1‐TR000445UL1‐TR002243R01‐AG034962R01‐AG056534U19‐AG03655NIAAG021155NIAAG027161NIAAG037639NIAAG054047U01AG024904 American Heart Association10.13039/100000968 26PRE1558066 Alzheimer's Association10.13039/100000957 IIRG‐08‐88733
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:12:12.594313+00:00
DOI: 10.1002/alz.71630 · PMC13338108